塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/10/10 | 1,229 | 1,229 | 1,205 | 1,213 | -20 | -1.6% | 2,580,700 |
2012/10/09 | 1,217 | 1,240 | 1,208 | 1,233 | +19 | +1.6% | 2,143,000 |
2012/10/05 | 1,207 | 1,246 | 1,207 | 1,214 | +40 | +3.4% | 2,594,100 |
2012/10/04 | 1,163 | 1,180 | 1,158 | 1,174 | +15 | +1.3% | 1,058,100 |
2012/10/03 | 1,177 | 1,177 | 1,149 | 1,159 | -28 | -2.4% | 1,416,300 |
2012/10/02 | 1,201 | 1,205 | 1,182 | 1,187 | +1 | +0.1% | 1,309,900 |
2012/10/01 | 1,191 | 1,202 | 1,175 | 1,186 | -6 | -0.5% | 1,295,200 |
2012/09/28 | 1,235 | 1,239 | 1,188 | 1,192 | -24 | -2% | 2,207,200 |
2012/09/27 | 1,185 | 1,221 | 1,181 | 1,216 | +46 | +3.9% | 2,256,500 |
2012/09/26 | 1,179 | 1,191 | 1,167 | 1,170 | -27 | -2.3% | 1,319,200 |
2012/09/25 | 1,195 | 1,208 | 1,190 | 1,197 | -2 | -0.2% | 1,545,800 |
2012/09/24 | 1,173 | 1,202 | 1,172 | 1,199 | +7 | +0.6% | 1,475,000 |
2012/09/21 | 1,180 | 1,200 | 1,175 | 1,192 | +24 | +2.1% | 1,584,700 |
2012/09/20 | 1,163 | 1,182 | 1,162 | 1,168 | +2 | +0.2% | 2,293,500 |
2012/09/19 | 1,184 | 1,190 | 1,165 | 1,166 | -11 | -0.9% | 2,243,200 |
2012/09/18 | 1,163 | 1,182 | 1,160 | 1,177 | +12 | +1% | 1,852,800 |
2012/09/14 | 1,181 | 1,183 | 1,158 | 1,165 | -4 | -0.3% | 3,894,300 |
2012/09/13 | 1,164 | 1,170 | 1,154 | 1,169 | +3 | +0.3% | 1,145,600 |
2012/09/12 | 1,141 | 1,166 | 1,136 | 1,166 | +26 | +2.3% | 1,175,300 |
2012/09/11 | 1,135 | 1,146 | 1,133 | 1,140 | +3 | +0.3% | 1,614,200 |
2012/09/10 | 1,139 | 1,147 | 1,134 | 1,137 | -2 | -0.2% | 939,600 |
2012/09/07 | 1,139 | 1,141 | 1,124 | 1,139 | +19 | +1.7% | 1,396,700 |
2012/09/06 | 1,125 | 1,130 | 1,112 | 1,120 | -3 | -0.3% | 1,226,500 |
2012/09/05 | 1,123 | 1,134 | 1,111 | 1,123 | -4 | -0.4% | 1,409,700 |
2012/09/04 | 1,136 | 1,138 | 1,119 | 1,127 | -2 | -0.2% | 1,530,000 |
2012/09/03 | 1,129 | 1,145 | 1,126 | 1,129 | +1 | +0.1% | 1,340,800 |
2012/08/31 | 1,135 | 1,142 | 1,125 | 1,128 | -9 | -0.8% | 1,484,700 |
2012/08/30 | 1,150 | 1,151 | 1,126 | 1,137 | -16 | -1.4% | 1,450,600 |
2012/08/29 | 1,159 | 1,168 | 1,147 | 1,153 | +4 | +0.3% | 1,479,300 |
2012/08/28 | 1,146 | 1,156 | 1,142 | 1,149 | +15 | +1.3% | 2,057,600 |
2012/08/27 | 1,141 | 1,146 | 1,134 | 1,134 | ±0 | ±0% | 839,300 |
2012/08/24 | 1,132 | 1,139 | 1,127 | 1,134 | -8 | -0.7% | 889,100 |
2012/08/23 | 1,142 | 1,144 | 1,131 | 1,142 | +6 | +0.5% | 1,730,700 |
2012/08/22 | 1,110 | 1,141 | 1,104 | 1,136 | +26 | +2.3% | 2,009,600 |
2012/08/21 | 1,100 | 1,111 | 1,098 | 1,110 | +16 | +1.5% | 1,409,000 |
2012/08/20 | 1,094 | 1,102 | 1,092 | 1,094 | +2 | +0.2% | 980,500 |
2012/08/17 | 1,108 | 1,108 | 1,091 | 1,092 | -14 | -1.3% | 1,335,700 |
2012/08/16 | 1,110 | 1,111 | 1,102 | 1,106 | +2 | +0.2% | 1,062,200 |
2012/08/15 | 1,115 | 1,115 | 1,096 | 1,104 | ±0 | ±0% | 1,375,200 |
2012/08/14 | 1,097 | 1,104 | 1,085 | 1,104 | +8 | +0.7% | 1,753,000 |
2012/08/13 | 1,094 | 1,103 | 1,093 | 1,096 | +5 | +0.5% | 722,100 |
2012/08/10 | 1,086 | 1,102 | 1,086 | 1,091 | -9 | -0.8% | 1,060,300 |
2012/08/09 | 1,092 | 1,104 | 1,083 | 1,100 | -2 | -0.2% | 1,622,800 |
2012/08/08 | 1,099 | 1,112 | 1,096 | 1,102 | +9 | +0.8% | 2,243,100 |
2012/08/07 | 1,090 | 1,095 | 1,083 | 1,093 | +8 | +0.7% | 1,446,700 |
2012/08/06 | 1,086 | 1,094 | 1,056 | 1,085 | +6 | +0.6% | 2,400,500 |
2012/08/03 | 1,075 | 1,081 | 1,062 | 1,079 | -25 | -2.3% | 1,989,100 |
2012/08/02 | 1,113 | 1,116 | 1,101 | 1,104 | -22 | -2% | 1,675,600 |
2012/08/01 | 1,121 | 1,137 | 1,116 | 1,126 | +8 | +0.7% | 1,523,300 |
2012/07/31 | 1,115 | 1,128 | 1,104 | 1,118 | +4 | +0.4% | 1,895,900 |
3151~
3200
件表示中 / 3773件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 255,000円 | +20.9% | +10.6% | 2.59% | 12.06倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 776,600円 | +2.2% | +28.0% | 1.80% | 12.43倍 | 1.51倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 162,000円 | +0.9% | +380.2% | 4.81% | 22.32倍 | 1.92倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 254,500円 | -3.5% | -11.3% | 2.36% | 23.37倍 | 1.58倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 453,800円 | +0.1% | -3.4% | 3.53% | 30.85倍 | 1.52倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム